JINS, the Tokyo-based optical retail group, is about to launch the second stage of its clinical research on the suppression of myopia progression, in partnership with Tsubota Laboratory, a startup from Keio University, one of the top universities in the country.
Buying a membership today will give you:
To continue reading this article register now.